Login / Signup

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

Linda M PakNancy E KemenyMarinela CapanuJoanne F ChouTaryn BoucherAndrea CercekVinod P BalachandranThomas Peter KinghamPeter J AllenRonald P DeMatteoWilliam R JarnaginMichael I D'Angelica
Published in: Journal of surgical oncology (2017)
Combination HAI and SYS is an effective therapy for high-volume unresectable CRLM, resulting in a high rate of resection, long-term survival, and the potential for cure.
Keyphrases
  • liver metastases
  • locally advanced
  • rectal cancer
  • human health
  • open label
  • randomized controlled trial
  • clinical trial
  • prognostic factors
  • study protocol
  • drug induced